Back to search

Current status of vinorelbine for breast cancer.

Data up to Jan 2025

Published1995
Citations36
References23

Total Citations Per Year

Abstract

References (23)

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.

1993 • 333 citations

Vinorelbine as first-line chemotherapy for metastatic breast carcinoma.

1994 • 191 citations

Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.

1994 • 164 citations

Preclinical and Clinical Pharmacology of Vinca Alkaloids

1992 • 158 citations

Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.

1993 • 157 citations

Phase-II study of Navelbine in advanced breast cancer.

1989 • 132 citations

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer.

1994 • 102 citations

Clinical Pharmacokinetics of Vinorelbine

1996 • 93 citations

In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence.

1989 • 93 citations

Cytochrome P450 3A-mediated human liver microsomal taxol 6 alpha-hydroxylation.

1994 • 82 citations

Phase I pharmacologic study of a new Vinca alkaloid: Navelbine

1985 • 80 citations

A summary of vinorelbine (Navelbine) safety data from North American clinical trials.

1994 • 78 citations

Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.

1994 • 64 citations

Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).

1987 • 58 citations

Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.

1994 • 53 citations

The Current and Future Place of Vinorelbine in Cancer Therapy

1992 • 48 citations

The clinical pharmacokinetics of vinorelbine (Navelbine).

1994 • 40 citations

Summary of data from in vitro and phase I vinorelbine (Navelbine) studies.

1994 • 32 citations

Overview of new treatments for breast cancer

1992 • 29 citations

A Review of the Antitumour Activity of Vinorelbine in Breast Cancer

1992 • 29 citations

Vinorelbine (Navelbine®). A New Semisynthetic Vinca Alkaloid

1991 • 29 citations

Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C

1993 • 24 citations

Menopause: Pharmacodynamics and pharmacokinetics

1994 • 18 citations

Cited By (0)

No citing papers found in database

Current status of vinorelbine for breast cancer. (1995) – PubMed | Metascience Observatory Explorer